Cellular responses to cytomegalovirus in immunosuppressed patients: Circulating CD8+ T cells recognizing CMVpp65 are present but display functional impairment

Clinical and Experimental Immunology

Volumn 132, Issue 1, 2003, Pages 96-104

  Engstrand, Mats ^a,b   Lidehall A K ^a   Totterman T H ^a   Herrman, B ^a   Eriksson, B M ^a   Korsgren, O ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

CD8 positive T lymphocytes; CMV; Cytomegalovirus; Flow cytometry; HLA; MHC

Indexed keywords

CD38 ANTIGEN; CD8 ANTIGEN; CMVPP65 PROTEIN; GAMMA INTERFERON; HLA A2 ANTIGEN; HLA ANTIGEN CLASS 1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; BLOOD DONOR; CELL LYSATE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOCYTOCHEMISTRY; LYMPHOCYTE FUNCTION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADP-RIBOSYL CYCLASE; ANTIGENS, CD; ANTIGENS, CD38; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; CYCLOSPORINE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HLA-A2 ANTIGEN; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; ORGAN TRANSPLANTATION; PHOSPHOPROTEINS; VIRAL MATRIX PROTEINS; VIRUS LATENCY;

EID: 0242416961     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02098.x     Document Type: Article

References (31)

1. Reusser P, Cathomas G, Attenhofer R, Tamm M, Thiel G. Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus load. J Infect Dis 1999; 180:247-53.
2. Lee PP, Yee C, Savage PA et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med 1999; 5:677-85.
3. + T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nat Med 1998; 4:953-6.
4. Li CR, Greenberg PD, Gilbert MJ, Goodrich JM, Riddell SR. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 1994; 83:1971-9.
5. + T lymphocytes using MHC tetramers in kidney transplant patients and healthy participants. Transplantation 2000; 69:2243-50.
6. Kostense S, Ogg GS, Manting EH et al. High viral burden in the presence of major HIV-specific CD8 (+) T cell expansions: evidence for impaired CTL effector function. Eur J Immunol 2001; 31 (3):677-86.
7. + cytotoxic lymphocyte responses against cytomegalovirus after liver transplantation: correlation with time from transplant to receipt of tacrolimus. J Infect Dis 2001; 183:835-43.
8. + T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J Clin Invest 1997; 99:1739-50.
9. Nomura LE, Walker JM, Maecker HT. Optimization of whole blood antigen-specific cytokine assays for CD4 (+) T cells. Cytometry 2000; 40:60-8.
10. Ghanekar SA, Nomura LE, Suni MA, Picker LJ, Maecker HT, Maino VC. Gamma interferon expression in CD8 (+) T cells is a marker for circulating cytotoxic T lymphocytes that recognize an HLA A2-restricted epitope of human cytomegalovirus phosphoprotein pp65. Clin Diagn Laboratory Immunol 2001; 8:628-31.
11. +T cell responses to CMV in HIV-1-infected subjects. Virology 2001; 279:459-70.
12. Sester M, Sester U, Gartner B et al. Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation. Transplantation 2001; 71 (9):1287-94.
13. Turner S, Ellexson ME, Hickman HD et al. Sequence-based typing provides a new look at HLA-C diversity. J Immunol 1998; 161:1406-13.
14. Yun Z, Lewensohn-Fuchs I, Ljungman P, Vahlne A. Real-time monitoring of cytomegalovirus infections after stem cell transplantation using the TaqMan polymerase chain reaction assays. Transplantation 2000; 69:1733-6.
15. Robbins PA, McMichael AJ. Immune recognition of HLA molecules downmodulates CD8 expression on cytotoxic T lymphocytes. J Exp Med 1991; 173:221-30.
16. Toyoda M, Carlos JB, Galera OA et al. Correlation of cytomegalovirus DNA levels with response to antiviral therapy in cardiac and renal allograft recipients. Transplantation 1997; 63:957-63.
17. Bitsch A, Kirchner H, Dennin R et al. The long persistence of CMV DNA in the blood of renal transplant patients after recovery from CMV infection. Transplantation 1993; 56:108-13.
18. + T lymphocytes in T cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood 2001; 98:1358-64.
19. Aubert G, Hassan-Walker AF, Madrigal JA et al. Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants. J Infect Dis 2001; 184:955-63.
20. Gamadia LE, Rentenaar RJ, Baars PA et al. Differentiation of cytomegalovirus-specific CD8 (+) T cells in healthy and immunosuppressed virus carriers. Blood 2001; 98:754-61.
21. Malamud D, Gonzalez EM, Chiu H, Malt RA. Inhibition of cell proliferation by azathioprine. Cancer Res 1972; 32:1226-9.
22. Fulton B, Markham A. Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation. Drugs 1996; 51:278-98.
23. Kern F, Bunde T, Faulhaber N et al. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. J Infect Dis 2002; 185:1709-16.
24. Yang HY, Dundon PL, Nahill SR, Welsh RM. Virus-induced polyclonal cytotoxic T lymphocyte stimulation. J Immunol 1989; 142:1710-8.
25. Busch DH, Pamer EG. T cell affinity maturation by selective expansion during infection. J Exp Med 1999; 189:701-10.
26. Wills MR, Carmichael AJ, Mynard K et al. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol 1996; 70:7569-79.
27. Kern F, Faulhaber N, Frommel C et al. Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides. Eur J Immunol 2000; 30:1676-82.
28. Picker LJ, Singh MK, Zdraveski Z et al. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 1995; 86:1408-19.
29. + T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med 1998; 187:1395-402.
30. + T cell subset in kidney transplant recipients. Transplantation 1998; 65:279-82.
31. Benz C, Utermohlen O, Wulf A et al. Activated virus-specific T cells are early indicators of anti-CMV immune reactions in liver transplant patients. Gastroenterology 2002; 122:1201-15.